These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28272733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ▼Guanfacine for ADHD in children and adolescents.
    Drug Ther Bull; 2016 May; 54(5):56-60. PubMed ID: 27173784
    [Abstract] [Full Text] [Related]

  • 7. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V, Haim Erder M, Xie J, Macaulay D, Diener M, Hodgkins P, Wu EQ.
    Pharmacoeconomics; 2012 Aug 01; 30(8):e1-15. PubMed ID: 22788263
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
    Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, Lyne A, Bloomfield R, Sikirica V, Robertson B.
    Eur Neuropsychopharmacol; 2014 Dec 01; 24(12):1861-72. PubMed ID: 25453486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Rizzo R, Martino D.
    Expert Rev Neurother; 2015 Apr 01; 15(4):347-54. PubMed ID: 25800130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
    Harstad E, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, Friedman S, LaRosa A, Loe IM, Mittal S, Tulio S, Vanderbilt D, Blum NJ.
    JAMA; 2021 May 25; 325(20):2067-2075. PubMed ID: 33946100
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
    Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J.
    J Am Acad Child Adolesc Psychiatry; 2013 Sep 25; 52(9):921-30. PubMed ID: 23972694
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
    Huang YS, Tsai MH.
    CNS Drugs; 2011 Jul 25; 25(7):539-54. PubMed ID: 21699268
    [Abstract] [Full Text] [Related]

  • 15. Guanfacine extended-release (intuniv) for ADHD.
    Med Lett Drugs Ther; 2010 Oct 18; 52(1349):82-3. PubMed ID: 21045757
    [No Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S, Adamo N, Mohr-Jensen C, Hayes AJ, Bhatti S, Carucci S, Del Giovane C, Atkinson LZ, Banaschewski T, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A, Coghill D, European ADHD Guidelines Group (EAGG).
    BMJ Open; 2017 Jan 10; 7(1):e013967. PubMed ID: 28073796
    [Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
    Wigal SB, Chae S, Patel A, Steinberg-Epstein R.
    Semin Pediatr Neurol; 2010 Dec 10; 17(4):230-6. PubMed ID: 21183129
    [Abstract] [Full Text] [Related]

  • 18. [Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe].
    Häge A, Banaschewski T, Dittmann RW.
    Fortschr Neurol Psychiatr; 2015 Dec 10; 83(12):676-85. PubMed ID: 26714249
    [Abstract] [Full Text] [Related]

  • 19. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR.
    Postgrad Med; 2010 Sep 10; 122(5):78-87. PubMed ID: 20861591
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.
    Kaplan G, Newcorn JH.
    Pediatr Clin North Am; 2011 Feb 10; 58(1):99-120, xi. PubMed ID: 21281851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.